The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation

This publication has 8 references indexed in Scilit:

• EFFECT OF CYCLOSPORINE ON MYCOPHENOLIC ACID TROUGH LEVELS IN KIDNEY TRANSPLANT RECIPIENTS1
  Transplantation, 1999
• Drug Interaction Between Mycophenolate Mofetil and Tacrolimus Detectable Within Therapeutic Mycophenolic Acid Monitoring in Renal Transplant Patients
  Therapeutic Drug Monitoring, 1999
• A RANDOMIZED DOUBLE-BLIND, MULTICENTER PLASMA CONCENTRATION CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ORAL MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION1
  Transplantation, 1999
• Evidence That Tacrolimus Augments the Bioavailability of Mycophenolate Mofetil Through the Inhibition of Mycophenolic Acid Glucuronidation
  Therapeutic Drug Monitoring, 1999
• Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoring
  The Journal of Heart and Lung Transplantation, 1999
• Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings
  Transplant Immunology, 1997
• A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1
  Transplantation, 1996
• MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTS
  Transplantation, 1995